- Home
- AVTX vs INSE Comparison
AVTX vs INSE Comparison
Compare AVTX & INSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- INSE
- Stock Information
- Founded
- AVTX 2011
- INSE 2002
- Country
- AVTX United States
- INSE United States
- Employees
- AVTX N/A
- INSE N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- INSE Computer Software: Prepackaged Software
- Sector
- AVTX Health Care
- INSE Technology
- Exchange
- AVTX Nasdaq
- INSE Nasdaq
- Market Cap
- AVTX 248.3M
- INSE 233.4M
- IPO Year
- AVTX 2015
- INSE N/A
- Fundamental
- Price
- AVTX $17.99
- INSE $8.00
- Analyst Decision
- AVTX Strong Buy
- INSE Buy
- Analyst Count
- AVTX 9
- INSE 6
- Target Price
- AVTX $30.14
- INSE $13.50
- AVG Volume (30 Days)
- AVTX 417.9K
- INSE 98.9K
- Earning Date
- AVTX 11-07-2025
- INSE 11-05-2025
- Dividend Yield
- AVTX N/A
- INSE N/A
- EPS Growth
- AVTX N/A
- INSE N/A
- EPS
- AVTX N/A
- INSE 2.11
- Revenue
- AVTX $441,000.00
- INSE $300,800,000.00
- Revenue This Year
- AVTX N/A
- INSE $4.50
- Revenue Next Year
- AVTX N/A
- INSE N/A
- P/E Ratio
- AVTX N/A
- INSE $3.79
- Revenue Growth
- AVTX N/A
- INSE N/A
- 52 Week Low
- AVTX $3.39
- INSE $6.51
- 52 Week High
- AVTX $19.41
- INSE $11.61
- Technical
- Relative Strength Index (RSI)
- AVTX 69.56
- INSE 36.61
- Support Level
- AVTX $15.58
- INSE $7.82
- Resistance Level
- AVTX $19.20
- INSE $8.88
- Average True Range (ATR)
- AVTX 1.66
- INSE 0.46
- MACD
- AVTX 0.26
- INSE -0.03
- Stochastic Oscillator
- AVTX 77.22
- INSE 23.49
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments, namely Gaming, Virtual Sports, Interactive, and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.